The Joseph Henry Press, an imprint of the National Academy Press, was created with the goal of making books on science, technology, and health more widely available to profes- sionals and the public.

Yarrowia lipolytica has emerged as a versatile yeast platform for biotechnological applications ranging from biofuel synthesis to high-value chemical production. Its oleaginous nature and robust ...

The Nature Index tracks primary research articles from 145 natural-science and health-science journals, chosen based on reputation by an independent group of researchers. The Nature Index provides ...

Andy Lin talks about his role at the major biotech company and his role as a mentor on the Industrial Advisory Board (IAB) for Northwestern Engineering's Master of Biotechnology Program (MBP). Andy ...

Unfortunately, this book can't be printed from the OpenBook. If you need to print pages from this book, we recommend downloading it as a PDF. Visit NAP.edu/10766 to get more information about this ...

Engineering biology is a tremendously powerful approach to finding sustainable alternatives to finite resources. However, it takes lots of time, money, and effort to develop the optimal microorganisms ...

In a small laboratory in Northbrook, Illinois, a team of scientists is trying to define the future of medicine. They aren't mixing chemicals in beakers or peering through microscopes. Instead, they ...

Cutting-edge cellular engineering firm, MaxCyte, has developed a platform, which enables modifications to cells. Applications of MaxCyte's cellular engineering platform are far-reaching, such as ...

Karen Lucatero presents the Colombian Case Study at UNIDO Headquarters in Vienna in December 2019. Karen Lucatero's passion for helping people has taken her from a biotechnology engineering background ...

Consortium's technology for synthetic protein engineering offers access to one of the next hot fields in biotechnology WASHINGTON -- Proteins! That's what his elders would tell Dustin Hoffman to ...

Despite-a rocky start on Wall Street, the biotechnology industry is here to stay. The growing recognition that it will soon be possible to modify existing biological proteins or design new ones to ...

Acute myeloid leukemia (AML) isn’t the most commonly known cancer. It is, however, one of the deadliest—an awful rare malignancy of the blood and bone marrow whose victims are already older and frail, ...